NDAOPHTHALMICSOLUTION/DROPS
Approved
Dec 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPTIPRANOLOL (metipranolol hydrochloride) is a non-selective beta-adrenergic antagonist ophthalmic solution approved for topical use in the eye. It reduces intraocular pressure in glaucoma and ocular hypertension patients by decreasing aqueous humor production. This small-molecule eye drop is a established therapeutic option in the glaucoma treatment armamentarium.
LOE Approaching
Product is in late-stage maturity with LOE approaching, signaling potential team consolidation and transition focus toward generic/authorized generic strategies rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
OPTIPRANOLOL roles are declining as the product approaches loss of exclusivity; career positions are primarily defensive and focused on brand protection, generic transition, and channel management rather than growth and innovation. Opportunities exist in market access and regulatory affairs related to authorized generic strategies, but overall hiring is expected to be limited.
Brand Manager
Worked on OPTIPRANOLOL at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.